AstraZeneca PLC
OpenCalais Metadata: Ticker
OpenCalais Metadata: LegalName
Bloomberg: EU Member States to Build Herd Immunity by End June, Bulgaria Lags Far Behind
Most European Union member states will have sufficient Covid vaccine supplies to immunize the majority of people by the end of June, much earlier than the bloc's official target, according to an internal memo seen by Bloomberg.
Russia’s Sputnik V Vaccine to Be Produced in Italy amid Approval Row with EMA
Russia is pushing ahead with plans to make its Covid-19 vaccine in Europe, securing a deal to produce the Sputnik V shot in Italy and discussing production in Germany and France.
Adienne Pharma & Biotech SA signed an agreement to manufacture the vaccine at its production site in the Milan region, founder and President Antonio Francesco Di Naro told Bloomberg in an interview
AstraZeneca buying drug developer Alexion for $39 billion
Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion.
Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said on Dec. 12 it's using a combination of cash and shares for the acquisition of Boston-based Alexion Pharmaceuticals Inc.